Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Ozempic and Wegovy have been plagued by supply shortages
Retatrutide is a synthetic triple-receptor agonist peptide targeting the GLP-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR) simultaneously, studied extensively across metabolic biology, obesity research, energy expenditure, and cardiovascular science for its unmatched tri-agonist incretin action and superior metabolic influence compared to single and dual-receptor compounds making it the most advanced and broadly acting incretin research peptide currently available in modern metabolic science
Lazzati A, Iannelli A, Schneck AS, et al
Updated June 20, 2025
Those controlled study amounts describe a different route and cannot be converted into subcutaneous syringe units or oral amounts
This timeline makes sense because your body needs a little time to absorb and start using the nutrients effectively
US$ 28.84
US$ 21.92
US$ 22.75
US$ 29.58
US$ 25.61
US$ 27.20
US$ 25.81
US$ 28.00
